Danhong Injection in the Treatment of Unstable Angina Pectoris

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

August 31, 2017

Study Completion Date

November 30, 2017

Conditions
Unstable Angina Pectoris
Interventions
DRUG

Danhong injection

A kind of injection made from two kind of Chinese herbs: salvia miltiorrhiza and safflower

OTHER

Standard medical care

Standard medical care is in accordance with China Guideline for the diagnosis and treatment of unstable angina (UA) and non-ST-elevation myocardial infarction (NSTEMI) (2007) issued by Chinese Society of Cardiology of Chinese Medical Association

DRUG

Placebo

0.9% saline added into 250ml 0.9% saline by an independent research nurse, sealed with brown bag in order to make the investigators and patients blinded, using brown infusion tube for infusion.

Trial Locations (9)

100053

Xuanwu Hospital, Beijing

100700

Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine, Beijing

110046

Hospital 463 of P.L.A., Shenyang

130021

The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun

150040

The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin

300193

First Teaching Hospital of Tianjin University of T.C.M., Tianjin

410005

The First Hospital of Changsha, Changsha

450006

Zhengzhou No.7 People's Hospital, Zhengzhou

510405

The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou

All Listed Sponsors
collaborator

China Food and Drug Administration

OTHER_GOV

lead

China Academy of Chinese Medical Sciences

OTHER

NCT02007187 - Danhong Injection in the Treatment of Unstable Angina Pectoris | Biotech Hunter | Biotech Hunter